Hospital Medicines List

Enter at least 4 characters

4 results showing for: 'lamivudine'

  1. Nucleoside Reverse Transcriptase Inhibitors
Abacavir sulphate with lamivudine    Medsafe Data Sheets   New Zealand Formulary.   Community Schedule.   HML PDF Schedule - Refer from page 102.
  • Restricted. Tab 600 mg with lamivudine 300 mg - 5% DV May-23 to 2025 (PSS)
    • Brand Abacavir/lamivudine Viatris
    • Pharmacode2632365
    • Subsidy $29.50
    • Measure / Qty per 30
RS1899 - Nucleoside Reverse Transcriptase Inhibitors
  1. Nucleoside Reverse Transcriptase Inhibitors
Lamivudine    Medsafe Data Sheets   New Zealand Formulary.   Community Schedule.   HML PDF Schedule - Refer from page 102.
  • Restricted. Tab 150 mg - 5% DV Feb-24 to 2026
    • Brand Lamivudine Alphapharm
    • Pharmacode2444526
    • Subsidy $84.50
    • Measure / Qty per 60
    • Brand Lamivudine Viatris
    • Pharmacode2638045
    • Subsidy $98.00
    • Measure / Qty per 60
    (Lamivudine Alphapharm Tab 150 mg to be delisted 01 November 2023)
  • Restricted. Oral liq 10 mg per ml
    • Brand Any brand
    • Pharmacode—
    • Subsidy—
    • Measure / Qty—
RS1899 - Nucleoside Reverse Transcriptase Inhibitors
  1. Hepatitis B
Lamivudine    Medsafe Data Sheets   New Zealand Formulary.   Community Schedule.   HML PDF Schedule - Refer from page 104.
  • Tab 100 mg - 5% DV Feb-24 to 2026 (PSS)
    • Brand Zetlam
    • Pharmacode2399369
    • Subsidy $12.06
    • Measure / Qty per 28
  • Oral liq 5 mg per ml
    • Brand Zeffix
    • Pharmacode307696
    • Subsidy $270.00
    • Measure / Qty per 240 ml
  1. Nucleoside Reverse Transcriptase Inhibitors
Zidovudine [AZT] with lamivudine    Medsafe Data Sheets   New Zealand Formulary.   Community Schedule.   HML PDF Schedule - Refer from page 103.
  • Restricted. Tab 300 mg with lamivudine 150 mg
    • Brand Alphapharm
    • Pharmacode2399377
    • Subsidy $92.40
    • Measure / Qty per 60
    • Brand Lamivudine/Zidovudine Viatris
    • Pharmacode2645300
    • Subsidy $92.40
    • Measure / Qty per 60
RS1899 - Nucleoside Reverse Transcriptase Inhibitors
  • Rectangle page icon symoblising a PDF. PDF
  • Two duplicate pages icon. Click to copy
  • Restriction. Restriction
  • HSS Hospital Supply Status
  • PSS Principal Supply Status
  • dv DV Limit Gives the maximum volume that can be purchased of other brands



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.